HM Hospitals Health Research Institute (IISHM)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Professor of Pharmacology and Vice-Chancellor for Research and Science at Camilo José Cela University (Madrid), and research member of the 12 de Octubre Hospital Research Institute and the HM Hospitals Health Research Institute (IISHM)
Pharmacogenomics studies how certain genes in a person – known as pharmacogenes – influence their response to medicines and the way in which the body metabolises them. One of the obstacles to its widespread adoption is the lack of diversity in research, as there is a scarcity of genetic data on groups of African and non-European descent. Now, a study published in Science Translational Medicine has analysed genetic and medication data from a diverse group of nearly 100,000 Americans participating in the All of Us medical initiative. 100 per cent had at least one variant in one of the 16 pharmacogenes, and 24.4 per cent had taken a medicine whose effect would be affected by one of those variants.
A meta-analysis published in the journal JAMA Psychiatry showed that psychedelic-assisted therapy is no more effective against depression than traditional antidepressants in clinical trials. The research found differences in the use of double-blind methods—that is, when neither the participants nor the researchers know which treatment each group is receiving—which minimises subjective influences on the results. Double-blinding made a difference in the case of traditional drugs, but not in the case of psychedelics, confirming that these trials are, in practice, always open-label.
Several recent studies had concluded that the risk of gastric cancer doubled with the use of drugs such as omeprazole – proton pump inhibitors. A new study published in The BMJ states that there is no association between prolonged use of these drugs and the risk of gastric adenocarcinoma. The research used prospective data from registries in Denmark, Finland, Iceland, Norway, and Sweden between 1994 and 2020. The study included more than 17,000 patients with gastric adenocarcinoma (other than cardia cancer) who had been exposed to these drugs for more than one year.